Ethiopia Pharmaceutical Market 2022-2030

    Multi User License - $2,999

    In Stock

    Coming Soon




    Majority of Ethiopia’s pharmaceutical requirements are now imported; this is a significant need that local manufacture has not yet been able to meet.


    Infographics:Ethiopia Pharmaceutical Market , Ethiopia Pharmaceutical Market Size, Ethiopia Pharmaceutical Market Trends, Ethiopia Pharmaceutical Market Forecast, Ethiopia Pharmaceutical Market Risks, Ethiopia Pharmaceutical Market Report, Ethiopia Pharmaceutical Market Share

    Ethiopia is also struggling with the delivery of various medical products disguised as counterfeit goods, as well as the trafficking of subpar and fake pharmaceuticals.


    The majority of over-the-counter medications in the nation are found at clinics and hospitals. 


    Ethiopia is a landlocked nation in Eastern Africa that shares borders with South Sudan, Eritrea, Kenya, Somalia, and Sudan. Ethiopia’s terrain is made up of high plateaus, with the Great Rift Valley dividing the country’s major mountain range. 


    Ethiopia’s manufacturing sector is still developing, and the pharmaceutical sector is no exception. With the assistance of the state and an active local market, things are going quickly.


    The landscape of the pharmaceutical sector has undergone tremendous transformation.



     The Ethiopia Pharmaceutical Market accounted for $XX Billion in 2021 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2022 to 2030.



    The Ethiopian government unveiled its “National strategy and plan of action for pharmaceutical manufacturing development in Ethiopia” during the third Financing for Development Conference in Addis Abeba.


    The strategic plan lays out specific, time-bound objectives for a variety of related, complementary operations with the intention of modernising Ethiopia’s pharmaceutical industry and increasing output to satisfy regional demand for critical medications.


    The government is pushing for increased local production to decrease Ethiopia’s reliance on imported medications.


    A manufacturing facility owned by the Indian company Glocare Pharma, with a capacity to produce 600 million tablets and 7 million capsules of medication annually, was opened at Kilinto Industrial Park.


    The government has set aside Kilinto IP specifically for the production of medical goods, with the goal of eventually replacing 50–60% of the demand for pharmaceuticals with locally produced goods.



    • Addis Pharmaceutical Factory Plc
    • Epharm
    • Medtech
    • Barcot Pharmaceuticals Plc. Beker Pharmaceuticals
    • East African Pharmaceuticals Plc
    • Fewes Pharmaceuticals Factory
    • Loul Pharmaceuticals Trading Plc
    • Pharmaceutical & Medical Supplies Import & Wh. Pharmacure Plc
    • Rx Africa (Ethiopia) Plc-Ethio-American Pharm



    1. What is the average cost per Ethiopia Pharmaceutical Market right now and how will it change in the next 5-6 years?
    2. Average cost to set up a Pharmaceutical Market in Ethiopia?  
    3. How many Ethiopia Pharmaceutical Market are manufactured per annum globally? Who are the sub-component suppliers in different regions?
    4. What is happening in the overall public, globally?
    5. Cost breakup of a Ethiopia Pharmaceutical Market and key vendor selection criteria
    6. Where is the Ethiopia Pharmaceutical Market  manufactured? What is the average margin per equipment?
    7. Market share of Ethiopia Pharmaceutical Market manufacturers and their upcoming products
    8. The most important planned Ethiopia Pharmaceutical Market in next 2 years
    9. Details on network of major Ethiopia Pharmaceutical Market and pricing plans
    10. Cost advantage for OEMs who manufacture Ethiopia Pharmaceutical Market in-house
    11. 5 key predictions for next 5 years in Ethiopia Pharmaceutical Market
    12. Average B-2-B Ethiopia Pharmaceutical Market price in all segments
    13. Latest trends in Ethiopia Pharmaceutical Market, by every market segment
    14. The market size (both volume and value) of Ethiopia Pharmaceutical Market in 2022-2030 and every year in between?
    15. Global production breakup of Ethiopia Pharmaceutical Market, by suppliers and their OEM relationship


    Sl no Topic
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2022-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2022-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2022-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2022-2030
    21 Product installation rate by OEM, 2022
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2022
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
      Your Cart
      Your cart is emptyReturn to Shop